Which companies overlap with Juno Therapeutics, Inc., a Bristol-Myers Squibb Company's portfolio?

Top competitors by shared drug class: Beijing Yongtai Ruike Biotechnology Company Ltd, Celgene, Celyad Oncology SA, Chongqing Precision Biotech Co., Ltd, EdiGene Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/juno-therapeutics-inc-a-bristol-myers-squibb-company.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company pipeline: 0 marketed, 0 filed, 3 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
BMS-986353	BMS-986353	phase 3	CAR-T cell therapy	Tumor-associated antigen (specific target not publicly disclosed in detail)	Oncology
BMS-986393	BMS-986393	phase 3	CAR-T cell therapy	CD19	Oncology
Liso-cel	Liso-cel	phase 3	CAR-T cell therapy	CD19	Oncology

Therapeutic area mix

Oncology · 4

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Beijing Yongtai Ruike Biotechnology Company Ltd · 1 shared drug class
Celgene · 1 shared drug class
Celyad Oncology SA · 1 shared drug class
Chongqing Precision Biotech Co., Ltd · 1 shared drug class
EdiGene Inc. · 1 shared drug class
Gruppo Italiano Malattie EMatologiche dell'Adulto · 1 shared drug class
Guangzhou Bio-gene Technology Co., Ltd · 1 shared drug class
Addrenex Pharmaceuticals, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Juno Therapeutics, Inc., a Bristol-Myers Squibb Company:

Cite this brief

Drug Landscape (2026). Juno Therapeutics, Inc., a Bristol-Myers Squibb Company — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/juno-therapeutics-inc-a-bristol-myers-squibb-company. Accessed 2026-05-17.